PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Citius Pharmaceuticals, Inc.
Filed: March 12, 2021
Period of Report: March 12, 2021
Accession Number: 0001213900-21-015112

View Document ↗ View on SEC.gov ↗